Budget Impact Analysis of the Change in Peritoneal Dialysis Use Rate in Korea

Author:

Kim Jimin1,Lee Na Rae1,Son Soo Kyung1,Lee Jung Pyo23,Park Jung Tak4,Kim Yun Jung1,Ryu Dong-Ryeol15

Affiliation:

1. National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea

2. Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea

3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

4. Department of Internal Medicine, Yonsei University Medical College, Seoul, Korea

5. Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea

Abstract

Background While the number of peritoneal dialysis (PD) patients has decreased by 14.4% from 2006 to 2016, the number of hemodialysis (HD) patients has sharply increased, by 237.2%, in the same period, leading to an increase in the total medical cost. We analyzed the effects of the changes in PD use rates for dialysis patients in Korea on the healthcare budget using budget impact analysis (BIA). Methods The analysis modeled the influence of the increase in dialysis for the target population, changes in modality use rate, and/or changes in costs per patient-year on total medical cost for patients on dialysis, using the National Health Insurance Service (NHI) claims data. We developed 8 scenarios according to the changing PD use rate. Results In scenarios 1 – 4 (increase in PD patients by 6%, 13%, 20%, and 50% of non-diabetic prevalent HD patients under 65), 5-year budget savings ranged from $47 million to $394 million (0.9% – 7.3% of the end-stage renal disease [ESRD] budget). In scenarios 5 – 8 (increase in incident PD patients by 20%, 50%, 70%, and 100% of non-diabetic patients under 65), 5-year savings ranged from $25 million to $74 million (0.5% – 1.4% of the ESRD budget). In all scenarios, budget savings were higher as PD patients increased, showing a gradually growing trend. Conclusion In all scenarios from the payer's perspective, savings could be achieved through an increase in PD use. Selecting PD for ESRD patients without different expected clinical outcomes between HD and PD would be beneficial to the NHI budget.

Publisher

SAGE Publications

Subject

Nephrology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3